Upsher-Smith Kicks off 2020 with Three Generic Product Launches

Company Strengthens Its Generic Portfolio with Rapid Product Expansion Maple Grove, MN – February 19, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its generic portfolio with the recent launch of three ...

Upsher-Smith and the National Alliance of State Pharmacy Associations (NASPA) Recognize 44 U.S. Pharmacists with Excellence in Innovation Award

Awardees Selected for Their Commitment to Patients and Effort in Advancing the Pharmacy Profession Maple Grove, MN – February 18, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are ...

Upsher-Smith to Attend 2019 Annual Meeting of The American Epilepsy Society

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the 2019 Annual Meeting of the American Epilepsy Society (AES) December 6-10, 2019 in Baltimore, MD. Meeting attendees are encouraged to visit booth #526 ...

Upsher-Smith Laboratories Adds Zembrace Symtouch (sumatriptan) Injection to its Access Pathways Platinum Pass Savings Program

Program Provides Access and Affordability for Patients Seeking Treatment for Acute Migraine Maple Grove, MN – November 18, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added Zembrace^® SymTouch^® (sumatriptan) Injection 3 mg ...

Steve Moore of Plattsburgh, New York Honored with 2019 Willard B. Simmons Independent Pharmacist of the Year Award

Left to Right: NCPA President Bill Osborn,PharmD; Steve Moore, PharmD (winner); and Mike McBride of Upsher Smith NCPA AWARD SPONSORED BY UPSHER-SMITH FOR ELEVENTH CONSECUTIVE YEAR Maple Grove, MN – October 29, 2019 – Upsher-Smith Laboratories, LLC ...

Upsher-Smith to Attend the 48th Annual Meeting of the Child Neurology Society

VISIT BOOTH #414 TO LEARN ABOUT VIGADRONE^® (VIGABATRIN) FOR ORAL SOLUTION AND ITS SAVINGS AND SUPPORT PROGRAM Maple Grove, MN – October 22, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending ...

Minnesota Governor Meets with Executives from Upsher-Smith’s Parent Company During Visit to Japan

Maple Grove, MN – September 20, 2019 – UpsherSmith Laboratories, LLC (Upsher-Smith) today announced that executives from its parent company, Sawai Pharmaceutical Co., Ltd. (Sawai) including Sawai’s President, Mitsuo Sawai and General Manager of External ...

Upsher-Smith Laboratories Completes Acquisition of Tosymra (sumatriptan) Nasal Spray and Zembrace SymTouch (sumatriptan) Injection

STRATEGIC ACQUISITION OF TOSYMRA^™ (SUMATRIPTAN) NASAL SPRAY AND ZEMBRACE^® SYMTOUCH^® (SUMATRIPTAN) INJECTION FURTHER EXPANDS AND DIVERSIFIES COMPANY’S PORTFOLIO Maple Grove, MN – July 20, 2019 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has completed ...

Upsher-Smith to Commercialize Klor-Con and Potassium Chloride Product Families

Maple Grove, MN – July 1, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that effective July 1, 2019 it will commercialize the KLOR-CON^® (potassium chloride) and Potassium Chloride product families and will continue its ...

Upsher-Smith Laboratories Enters Into Agreement to Acquire Tosymra (Sumatriptan Nasal Spray) and Zembrace Symtouch (Sumatriptan Injection)

STRATEGIC ACQUISITION DIVERSIFIES COMPANY’S PORTFOLIO AND PROVIDES NEW OPTIONS FOR MIGRAINE PATIENTS Maple Grove, MN – June 13, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has agreed to acquire US and other territory ...